GlassScriptPhysician profile
Katherine Morrison
NPI 1013668409
$1,654.60
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $842 · 2024: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $535.55 | 2023-2024 | Xtampza |
| Axsome Therapeutics, INC. | $168.24 | 2023-2024 | Auvelity |
| Valinor Pharma, LLC | $115.97 | 2023-2024 | Movantik |
| Otsuka America Pharmaceutical, INC. | $106.04 | 2023-2024 | Rexulti |
| Lundbeck LLC | $82.74 | 2023-2024 | Rexulti |
| Abbvie INC. | $78.65 | 2023-2024 | |
| Pfizer INC. | $68.87 | 2023-2024 | |
| Lilly USA, LLC | $67.42 | 2023-2024 | Mounjaro, Zepbound |
| Neurocrine Biosciences, INC. | $64.44 | 2023-2024 | Ingrezza |
| Alkermes, INC. | $58.16 | 2023-2024 | Vivitrol, Vivitrol |
| Janssen Pharmaceuticals, INC | $57.89 | 2023-2024 | Spravato |
| Uswm, LLC | $46.10 | 2023-2024 | Lucemyra, Zimhi |
| Scilex Pharmaceuticals INC. | $45.27 | 2023-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.72 | 2023-2024 | Relistor |
| Astellas Pharma US INC | $42.56 | 2024 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.75 | 2023-2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $25.19 | 2023 | Trintellix |
| Gilead Sciences, INC. | $14.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.